ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · IEX Real-Time Price · USD
1.810
+0.010 (0.56%)
Jul 19, 2024, 11:59 AM EDT - Market open

ProQR Therapeutics Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2013
Cash & Equivalents
85.71118.9394.78187.5275.84111.95
Upgrade
Short-Term Investments
1700000
Upgrade
Cash & Cash Equivalents
102.71118.9394.78187.5275.84111.95
Upgrade
Cash Growth
-26.10%25.48%-49.46%147.27%-32.26%6.03%
Upgrade
Receivables
3.821.5459.083.43.761.87
Upgrade
Other Current Assets
0.620.520.610.560.420.85
Upgrade
Total Current Assets
107.16120.99154.46191.4880.02114.67
Upgrade
Property, Plant & Equipment
16.7216.916.2417.4718.62.44
Upgrade
Long-Term Investments
000.620.630.110.43
Upgrade
Total Long-Term Assets
16.7216.916.8618.118.712.87
Upgrade
Total Assets
123.88137.88171.32209.5898.73117.54
Upgrade
Accounts Payable
0.331.540.390.190.220.45
Upgrade
Deferred Revenue
61.8364.7471.2119.80.70.71
Upgrade
Current Debt
5.851.613.896.312.40.85
Upgrade
Other Current Liabilities
-33.6-33.69-54.51.36.998.99
Upgrade
Total Current Liabilities
34.4234.220.9927.610.310.99
Upgrade
Long-Term Debt
13.3718.1218.0854.0731.8812.71
Upgrade
Other Long-Term Liabilities
41.2644.1765.5714.6900
Upgrade
Total Long-Term Liabilities
54.6462.2983.6568.7531.8812.71
Upgrade
Total Liabilities
89.0696.49104.6496.3542.1823.7
Upgrade
Total Debt
19.2319.7321.9760.3734.2813.56
Upgrade
Debt Growth
-10.24%-10.18%-63.61%76.13%152.78%44.47%
Upgrade
Retained Earnings
--400.85-379.11-317.77-257.75-211.75
Upgrade
Shareholders' Equity
34.8241.3967.07113.8357.0994.33
Upgrade
Net Cash / Debt
83.4999.1972.8127.1541.5698.39
Upgrade
Net Cash / Debt Growth
-28.99%36.24%-42.74%205.94%-57.76%2.28%
Upgrade
Net Cash Per Share
1.021.221.021.980.832.40
Upgrade
Working Capital
72.7486.78133.47163.8969.72103.67
Upgrade
Book Value Per Share
0.430.510.941.771.142.30
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).